Bill > S3030

Introduced Session

This bill would revise the definition of "inherently beneficial use in the "Municipal Land Use Law," P.L.1975, c.291 (C.40:55D-1 et seq.) (MLUL) to include a sterile syringe access program. Under the MLUL, if a use is deemed inherently beneficial it presumptively satisfies the positive criteria for the grant of a use variance under subsection d. of section 57 of P.L.1975, c.291 (C.40:55-70). Sterile syringe access programs are designed to prevent the spread of HIV, hepatitis C, and other blood borne pathogens, and have been proven effective in reducing the spread of these pathogens without adverse social impacts or an increase in drug abuse. Additionally, the programs provide drug users with a bridge to treatment and other social services. This bill would make it easier for the programs to be established, providing more individuals with access to the program benefits.

AI Summary

Committee Categories

Richard Codey (D)*,  Joe Vitale (D)*, 

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 10/15/2018)